SCHEMBL2267949

SCHEMBL2267949

Oc1ccc(O)c2[nH]cnc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 3/20 0.41
CSNK2A2 P19784 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
RAB9A P51151 1/20 0.41
CSNK2B P67870 1/20 0.41
DYRK1A Q13627 1/20 0.41
CSNK2A3 Q8NEV1 1/20 0.41
ALDH1A1 P00352 3/20 0.40
PKM P14618 1/20 0.40
BCL2 P10415 1/20 0.37
MCL1 Q07820 1/20 0.37
LMNA P02545 2/20 0.36
KDM4E B2RXH2 2/20 0.36
PNP P00491 1/20 0.36
POLB P06746 1/20 0.35
PIK3CG P48736 1/20 0.34
PIK3C3 Q8NEB9 1/20 0.34
PDPK1 O15530 1/20 0.34
BRD4 O60885 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL11590383 0.98 CSNK2A1 (0.40) CSNK2A1CSNK2A2MEN1KMT2ARAB9A
Bromide SCHEMBL11357233 0.98 CSNK2A1 (0.40) CSNK2A1CSNK2A2MEN1KMT2ARAB9A
Hydrochloric Acid SCHEMBL11589235 0.98 ALDH1A1 (0.42) CSNK2A1CSNK2A2MEN1KMT2ARAB9A
SCHEMBL6718557 0.85 PARP1 (0.42) CSNK2A1CSNK2A2MEN1KMT2ARAB9A
SCHEMBL4612063 0.83 PARP1 (0.41) ALDH1A1PKMPARP1
Hydrochloric Acid SCHEMBL14832033 0.83 PARP1 (0.41) CSNK2A1CSNK2A2MEN1KMT2ARAB9A
SCHEMBL4612059 0.83 SLC6A2 (0.43) CSNK2A1CSNK2A2MEN1KMT2ARAB9A
SCHEMBL14838063 0.83 IDO1 (0.43) CSNK2A1CSNK2A2MEN1KMT2ARAB9A
SCHEMBL2273204 0.78 ABL1 (0.47) CSNK2A1CSNK2A2MEN1KMT2ARAB9A
SCHEMBL2273213 0.78 ABL1 (0.47) CSNK2A1CSNK2A2MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120054636-A Preparation method of photocatalysis material for treating alizarin red sewage 北方工业大学 2025-05-30 CN claimed
EP-1002520-B1 Composition for oxidative dying of keratinous fibres and dying process therewith OREAL (FR) 2008-10-29 EP claimed
WO-2007071686-A1 COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE, AN OXIDATION BASE AND A PARTICULAR COUPLER L'ORÉAL (FR) 2007-06-28 WO claimed
US-6893470-B1 Keratinous fibre oxidation dyeing composition containing a laccase and dyeing method using same L'OREAL S.A. (FR) 2005-05-17 US claimed
US-6890362-B2 Oxidation dyeing composition for keratinous fibers and dyeing method using same L'OREAL, S.A. (FR) 2005-05-10 US claimed
US-20040231067-A1 Dyeing composition comprising a cationic tertiary para-phenylenediamine and heterocyclic coupler, methods and uses L'OREAL (FR) 2004-11-25 US claimed
EP-0988021-B1 KERATIN FIBRE OXIDATION DYEING COMPOSITION AND DYEING METHOD USING SAME OREAL (FR) 2003-11-12 EP claimed
US-20030009835-A1 Oxidation dyeing composition for keratinous fibres and dyeing method using same L'OREAL S.A. (FR) 2003-01-16 US claimed
US-6395042-B1 OXIDATION BASE, HETEROCYCLIC COUPLERS FOR OXIDATION COLOR DYE L'ORÉAL (FR) 2002-05-28 US claimed
EP-1181005-A1 OXIDATION DYEING COMPOSITION FOR KERATINOUS FIBRES AND DYEING METHOD USING SAME L'OREAL (FR) 2002-02-27 EP claimed
WO-1998055083-A1 KERATIN FIBRE OXIDATION DYEING COMPOSITION AND DYEING METHOD USING SAME L'OREAL (FR) 1998-12-10 WO claimed
US-5785717-A Composition for the oxidation dyeing of keratin fibers, comprising a diaminopyrazole derivative and a heterocyclic coupler, and dyeing process L'OREAL (FR) 1998-07-28 US claimed
US-5769903-A Composition for the oxidation dyeing of keratin fibers, comprising an oxidation base, an indole coupler and an additional heterocyclic coupler, and dyeing process L'OREAL (FR) 1998-06-23 US claimed
EP-0728464-B1 Composition for dyeing keratinous fibers comprising a diaminopyrazole derivative and a heterocyclic coupleur and dyeing process OREAL (FR) 1997-07-30 EP claimed
EP-0605320-B1 Dye composition for keratinic fibres based on paraphenylenediamine, metaphenylenediamines and benzimidazol derivates, and the dyeing process using same OREAL (FR) 1997-04-09 EP claimed
US-5578087-A Dyeing compositions for keratinous fibres based on para-phenylene-diamines, meta-phenylenediamine and benzimidazole derivatives, and dyeing process employing them L'OREAL (FR) 1996-11-26 US claimed
EP-0728466-A1 Keratinous fibers oxidation dyeing composition comprising an oxidation base, an indolic coupler and an additional heterocyclic coupler and dyeing process L'OREAL (FR) 1996-08-28 EP claimed
EP-0728464-A1 Composition for dyeing keratinous fibers comprising a diaminopyrazole derivative and a heterocyclic coupleur and dyeing process L'OREAL (FR) 1996-08-28 EP claimed
EP-0605320-A1 Dye composition for keratinic fibres based on paraphenylenediamine, metaphenylenediamines and benzimidazol derivates, and the dyeing process using same L'OREAL (FR) 1994-07-06 EP claimed
EP-0058839-B1 SENSITIZED ORGANIC ELECTRON DONOR COMPOUNDS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1986-04-16 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030009835-A1 Oxidation dyeing composition for keratinous fibres and dyeing method using same KRT18, PPOX, NDUFB5 CSNK2A1 1551/4885CSNK2A2 1514/4885MEN1 3718/4885
US-20040231067-A1 Dyeing composition comprising a cationic tertiary para-phenylenediamine and heterocyclic coupler, methods and uses KRT18, CDC73, PYCR1 CSNK2A1 2098/4885CSNK2A2 2253/4885MEN1 1172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.